Note: This grant page has been archived and is very likely out of date.

HEAL Initiative: Oral Complications Arising from Pharmacotherapies to Treat Opioid Use Disorders (R21 Clinical Trial Not Allowed)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

Deadline: The deadline for this grant has passed

Grant amount: Up to US $250,000

Fields of work: Addiction & Substance Use Disorders Pharmacology

Applicant type: Government Entity, Nonprofit, For-Profit Business, Indigenous Group

Funding uses: Research

Location of project: United States

Location of residency: United States


The purpose of this Funding Opportunity Announcement (FOA) is to solicit developmental/exploratory research to better understand the biology, natural history, and directionality of oral complications associated with pharmacotherapies used to treat opioid use disorders (OUDs). Further, this FOA will support research to explore access to care and other challenges that may contribute to dental and oral disease onset and progression in people with OUD.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

This page was last reviewed August 04, 2022 and last updated August 04, 2022